{"database": "openregs", "table": "documents", "rows": [["FDA-2008-D-0610-0008", "FDA", "FDA-2008-D-0610", "Draft Guidance for Industry; Availability Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During an Influenza Pandemic", "Notice", "NAD-Notice of Availability of Data", "2011-01-07T05:00:00Z", 2011, 1, "2011-01-07T05:00:00Z", "2011-03-09T04:59:59Z", "2011-03-03T20:47:47Z", "2011-00094", 0, 0, "0900006480bc6d37"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2008-D-0610-0008"], "units": {}, "query_ms": 0.49419491551816463, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}